CN Patent
CN104829465B — 一种4-异丙氨基-1-丁醇的制备方法
Assigned to Puji Biotechnology (Taizhou) Co., Ltd. · Expires 2018-04-27 · 8y expired
What this patent protects
本发明涉及一种4‑异丙氨基‑1‑丁醇的制备方法,采用价廉易得的四氢呋喃与溴化氢的乙酸溶液为起始原料,制备了新的中间体化合物4‑异丙氨基‑1‑乙酰氧基丁烷,进而制备了目标产物。本发明制备方法的优点在于工艺操作方便,反应条件温和,经济环保,获得高纯度、高收率的目标产物,适于产业化生产。
USPTO Abstract
本发明涉及一种4‑异丙氨基‑1‑丁醇的制备方法,采用价廉易得的四氢呋喃与溴化氢的乙酸溶液为起始原料,制备了新的中间体化合物4‑异丙氨基‑1‑乙酰氧基丁烷,进而制备了目标产物。本发明制备方法的优点在于工艺操作方便,反应条件温和,经济环保,获得高纯度、高收率的目标产物,适于产业化生产。
Drugs covered by this patent
- Uptravi (SELEXIPAG) · AstraZeneca
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.